---
title: "Alto Neuroscience Reports First Quarter 2026 Financial Results and Recent Business Highlights | ANRO Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286247939.md"
description: "Alto Neuroscience Reports First Quarter 2026 Financial Results and Recent Business Highlights | ANRO Stock News"
datetime: "2026-05-13T03:05:29.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286247939.md)
  - [en](https://longbridge.com/en/news/286247939.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286247939.md)
generator: "portal-rs"
---

# Alto Neuroscience Reports First Quarter 2026 Financial Results and Recent Business Highlights | ANRO Stock News

Alto Neuroscience Reports First Quarter 2026 Financial Results and Recent Business Highlights | ANRO Stock News

### Related Stocks

- [ANRO.US](https://longbridge.com/en/quote/ANRO.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)

## Related News & Research

- [ANRO: Precision psychiatry pipeline advances with biomarker-driven therapies and strong clinical data](https://longbridge.com/en/news/295708046.md)
- [Alto Neuroscience posts corporate presentation outlining precision psychiatry drug pipeline, led by ALTO-207 in treatment-resistant depression](https://longbridge.com/en/news/295705980.md)
- [EverGen Infrastructure Reports Q2 2026 Results | EVGIF Stock News](https://longbridge.com/en/news/297122882.md)
- [“We’re not doing 30 bets a year”: Vijay Pande on betting small after running $4 billion at a16z](https://longbridge.com/en/news/297407072.md)
- [Biotech Stocks Facing FDA Decision In September 2026](https://longbridge.com/en/news/297065559.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**